NCT01522248

Early Immune Responses to Inactivated Influenza Vaccine: a Pilot Study

A Pilot Study to Examine the Early Cytokine Responses After Inactivated Influenza Vaccination in Adults 18-50.

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: Johns Hopkins Bloomberg School of Public Health · Academic / Other
• Sex: All
• Age: 18 Years – 50 Years
• Healthy volunteers: Accepted

Summary

Some people experience symptoms just after receiving the seasonal inactivated influenza vaccine. The cause of some of these symptoms is likely to be an immune response to the vaccine. The investigators would like to look at the earliest immune responses to the inactivated influenza vaccine. This pilot study will help us to determine at what time points we should look.

Conditions

• Influenza Virus Vaccine

Interventions

Type	Name	Description
BIOLOGICAL	Trivalent Inactivated Influenza vaccine	0.5 ml IM once only

Timeline

• Start date: 2012-01-01
• Primary completion: 2012-02-01
• Completion: 2012-02-01
• First posted: 2012-01-31
• Last updated: 2019-03-15
• Results posted: 2019-03-15

Locations

1 site across 1 country: United States